Initiation of sulfonylureas versus metformin is associated with higher blood pressure at one year
暂无分享,去创建一个
A. Hung | C. Roumie | Xulei Liu | Carlos G. Grijalva | M. Griffin | R. Greevy | N. Choma
[1] Matthew S. Fritz,et al. Mediation analysis. , 2019, Annual review of psychology.
[2] Medicaid Services,et al. International Classification of Diseases, Ninth Revision, Clinical Modification , 2011 .
[3] Nisa M. Maruthur,et al. Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations , 2011, Annals of Internal Medicine.
[4] D. Jacobs,et al. Glucose, insulin, and incident hypertension in the multi-ethnic study of atherosclerosis. , 2010, American journal of epidemiology.
[5] A. Hung,et al. Glycemic and weight changes after persistent use of incident oral diabetes therapy: a veterans administration retrospective cohort study , 2010, Pharmacoepidemiology and drug safety.
[6] Craig I Coleman,et al. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. , 2010, JAMA.
[7] Kirsten Bibbins-Domingo,et al. Projected effect of dietary salt reductions on future cardiovascular disease. , 2010, The New England journal of medicine.
[8] David P. MacKinnon,et al. Current Directions in Mediation Analysis , 2009, Current directions in psychological science.
[9] V. Stevens,et al. Weight Change in Diabetes and Glycemic and Blood Pressure Control , 2008, Diabetes Care.
[10] Shari Bolen,et al. Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus , 2007, Annals of Internal Medicine.
[11] A. Diedrich,et al. Acarbose, an &agr;-Glucosidase Inhibitor, Attenuates Postprandial Hypotension in Autonomic Failure , 2007, Hypertension.
[12] F. Weaver,et al. Veterans’ Access to and Use of Medicare and Veterans Affairs Health Care , 2007, Medical care.
[13] M. Cheang,et al. Validity of a Prescription Claims Database to Estimate Medication Adherence in Older Persons , 2006, Medical care.
[14] R. D'Agostino,et al. Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study. , 2005, Archives of internal medicine.
[15] W. Ray,et al. Evaluating medication effects outside of clinical trials: new-user designs. , 2003, American journal of epidemiology.
[16] Daniel W. Jones,et al. Associations of weight loss and changes in fat distribution with the remission of hypertension in a bi-ethnic cohort: the Atherosclerosis Risk in Communities Study. , 2003, Preventive medicine.
[17] P. Whelton,et al. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. , 2000, Hypertension.
[18] P. Allison. Multiple Imputation for Missing Data , 2000 .
[19] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[20] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[21] Uk-Prospective-Diabetes-Study-Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.
[22] W. Manning,et al. The Cost to Health Plans of Poor Glycemic Control , 1997, Diabetes Care.
[23] T. Gilmer,et al. Predictors of health care costs in adults with diabetes. , 2005, Diabetes care.
[24] W. Rosamond,et al. Associations between weight gain and incident hypertension in a bi-ethnic cohort: the Atherosclerosis Risk in Communities Study , 2002, International Journal of Obesity.
[25] Yang C. Yuan,et al. Multiple Imputation for Missing Data: Concepts and New Development , 2000 .
[26] L. J. Wei,et al. The Robust Inference for the Cox Proportional Hazards Model , 1989 .